GM Foods: Two Views

I enjoyed reading the article "Fears or Facts? A Viewpoint on GM Crops."1 I second Peter Raven's remarks on genetically modified (GM) plants. The Europeans have obviously been misled by their media; hence, their irrational fear of GM food sources. Is it the Galileo syndrome all over again? Are we not manipulating genes when breeders make artificial crosses using gametes from a male and female plant to improve their varieties? Are we not already consuming hybrid corn, hybrid rice, and high-yieldi

Written byArdeshir Damania
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

I enjoyed reading the article "Fears or Facts? A Viewpoint on GM Crops."1 I second Peter Raven's remarks on genetically modified (GM) plants. The Europeans have obviously been misled by their media; hence, their irrational fear of GM food sources. Is it the Galileo syndrome all over again?

Are we not manipulating genes when breeders make artificial crosses using gametes from a male and female plant to improve their varieties? Are we not already consuming hybrid corn, hybrid rice, and high-yielding wheat varieties infused with the dwarfing gene?

More than a hundred years ago, farmers used to improve their crops by selecting plants from among their matured standing crops. They harvested the remainder and used the seeds from the selected plants for the next season's sowing. This way the best plants perpetuated themselves, and the farmer was able to develop his own varieties. These varieties, sometimes called "landraces," were suited ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies